Skeletal muscle health in childhood cancer survivors: a systematic review and meta-analysis
Abstract
Purpose: Childhood cancer survivors (CCS) are at risk of long-term skeletal muscle deficits following intensive therapies during critical periods of growth. This review aimed to synthesize approaches for assessing muscle quantity, quality, and function in CCS and to quantify deficits relative to healthy peers.
Methods: A systematic search was conducted in CINAHL, Embase, PubMed, SPORTDiscus, and Web of Science from inception to June 2024, with an update in November 2025. Studies including CCS who had completed cancer treatment and reported measures of muscle quantity, quality, or physical function were eligible. A three-level mixed-effects model meta-analysis was conducted. Associations between muscle quantity and function and potential moderators were tested using meta-regression models. Methodological quality was assessed using the Newcastle-Ottawa Scale.
Results: Forty-four studies comprising 5175 CCS were included. Compared to controls, CCS exhibited significantly lower muscle quantity (SMD -0.45; 95% CI -0.63 to -0.28; p < 0.001) and muscle function (SMD -0.41; 95% CI -0.57 to -0.24; p < 0.001). No studies evaluated muscle quality. Deficits in muscle function were more pronounced in the lower body than the upper body, and meta-regression analyses indicated greater muscle quantity deficits with increasing time since treatment completion.
Conclusion: Childhood cancer survivors exhibit significant deficits in muscle quantity and function. Future research should focus on…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Biportal endoscopic versus microscopic lumbar decompressive laminectomy in patients with spinal stenosis: A randomized controlled trial
- A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial
- Supplement-based nutritional strategies to tackle frailty: A multifactorial, double-blind, randomized placebo-controlled trial
- A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
- Creatine supplementation (3 g/day) and bone health in older women: a 2-year, randomized, placebo-controlled trial
- A Multi-Ingredient Nutritional Supplement in Combination With Resistance Exercise and High-Intensity Interval Training Improves Cognitive Function and Increases N-3 Index in Healthy Older Men: A Randomized Controlled Trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.